主编辑安装的抑制器tRNA用于疾病无关的基因组编辑
Sarah E Pierce1,2,3, Steven Erwood1,2,3, Keyede Oye1,2,3
1Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Nature
|November 19, 2025
概括
主编辑中介的过早终止编码子 (PERT) 提供一种疾病无关的基因疗法. 这种方法将内源性tRNA永久转化为抑制性tRNA (超级tRNA),以挽救无意义突变,可能治疗各种遗传疾病.
科学领域:
- 遗传学
- 分子生物学
- 生物技术
背景情况:
- 精确的基因组编辑工具,如基因和原始编辑,可以修复基因变异,但需要突变特异性代理.
- 导致过早停止的突变是抑制性tRNA (超级tRNA) 的目标,但目前的方法需要终身治疗或引起毒性.
- 现有的sup- tRNA疗法在效力方面存在局限性,需要持续使用.
研究的目的:
- 开发一种新的无病基因组编辑策略来拯救无意义的突变.
- 使用原始编辑设计一个优化的内源抑制器tRNA (sup-tRNA).
- 在遗传疾病模型中评估初始编辑介导的过早终止编码子 (PERT) 的治疗潜力.
主要方法:
- 使用原始编辑来永久地将可用的内源tRNA转换为优化的sup-tRNA.
- 选了成千上万的人类tRNA变体以确定具有最高的sup-tRNA潜力.
- 优化的原始编辑剂用于单位安装无过度表达的工程 sup-tRNA.
- 在巴顿病,泰-萨克斯病和囊性纤维化的人类细胞模型中测试PERT.
- 在Hurler综合征模型中,在体内给出了一个主要编辑器,将小鼠tRNA转换为sup-tRNA.
主要成果:
- 在细胞模型中实现过早终结的代和蛋白质救援的有效阅读.
- 在Hurler综合征的小鼠模型中,在体内PERT输送后,已经证明了广泛的疾病病理.
- 证实PERT没有诱导自然停止编码子的阅读.
- 没有观察到显著的转录或蛋白质变化.
- 识别了具有强大的sup-tRNA能力的特定tRNA变体.
结论:
- PERT是一种强大的,无病的基因组编辑策略,
- 这种方法可以通过内源性sup- tRNA产生永久性校正,避免终身的药物使用或过度表达的毒性.
- 一个单一的治疗药物可以通过向过早停止密码子来解决各种遗传疾病.
- 这些发现支持针对广泛的遗传疾病开发新的治疗基因组编辑方法.
相关概念视频
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
RNA Editing
9.7K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.7K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K


